Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer Larson currently holds 285,000 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Jennifer Larson has been a net neutral trader of BCAX stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Larson's most recent insider trade was on Aug 12, 2026, when they sold 285,000 shares at $0.00 per share.
Jennifer Larson serves as Chief Financial Officer at Bicara Therapeutics Inc. (BCAX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Jennifer Larson holds the position of Chief Financial Officer at Bicara Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Jennifer Larson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jennifer Larson was on Aug 12, 2026, when they purchased $0 worth of BCAX shares. This transaction involved 285,000 shares at N/A per share.
Jennifer Larson currently owns 285,000 shares of Bicara Therapeutics Inc. (BCAX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer Larson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer Larson has 1 Form 4 filings on record as an insider at Bicara Therapeutics Inc..
Set alerts for Jennifer Larson and 40,000+ other insiders.